The HLF gene protects blood stem cells by maintaining them in a resting stateMedical XpressMaintaining blood production, especially in the case of injury, chemotherapy or a transplantation, is dependent on a limited number of stem cells in the bone mar… Continue reading
PharmaTimes |
Speedy EU, US review for Novartis’ CAR–T therapy Kymriah
PharmaTimes Regulators on both sides of the Atlantic are undertaking speedy reviews of Novartis’ CAR–T therapy Kymriah as a treatment for some patients with elapsed or refractory (r/r) diffuse large B-cell lymphoma (DLBCL). In the US, the Food and Drug … Novartis’s Kymriah wins speedy reviews in US, EuropeWHTC Novartis granted US FDA Priority Review for Kymriah™ (tisagenlecleucel), formerly CTL019, for adults with r/r DLBCLMarkets Insider |